Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Pain 1Neurotoxicity Syndromes 1Neoplasms 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cycloserine × Breast × Clear all
NCT00903591 2026-06-03

Study of Radiation Exposure and Bilateral Breast Cancer

Memorial Sloan Kettering Cancer Center

Active not recruiting
1,699 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT00301080 2013-12-02

D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

Northwestern University

Phase 3 Terminated
7 enrolled 3 charts
Breast

Breast Neoplasms, Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡